DANIEL J BOOSER's research topics

DANIEL J BOOSER

Concepts (344)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with DANIEL J BOOSER's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that DANIEL J BOOSER has written about over time.

Antibiotics, Antineoplastic, 6 publications between 1994 and 2002, average publication date December 1997. Neutropenia, 9 publications between 1984 and 2023, average publication date July 2000. Doxorubicin, 30 publications between 1984 and 2015, average publication date April 2001. Antineoplastic Agents, Phytogenic, 12 publications between 1998 and 2003, average publication date June 2001. Cyclophosphamide, 21 publications between 1984 and 2012, average publication date September 2001. Lacrimal Duct Obstruction, 2 publications between 2001 and 2002, average publication date September 2001. Paclitaxel, 19 publications between 1993 and 2015, average publication date October 2002. Middle Aged, 77 publications between 1984 and 2019, average publication date May 2003. Fluorouracil, 20 publications between 1995 and 2012, average publication date June 2003. Antineoplastic Combined Chemotherapy Protocols, 46 publications between 1984 and 2023, average publication date December 2003. Neoplasm Metastasis, 21 publications between 1993 and 2019, average publication date December 2004. Breast Neoplasms, 76 publications between 1992 and 2019, average publication date February 2005. Antineoplastic Agents, Hormonal, 7 publications between 2000 and 2011, average publication date February 2006. Taxoids, 14 publications between 1998 and 2013, average publication date May 2006. Receptors, Estrogen, 12 publications between 2000 and 2012, average publication date February 2007. Receptor, ErbB-2, 9 publications between 2002 and 2019, average publication date June 2009. Sirolimus, 4 publications between 2011 and 2015, average publication date June 2012. Proto-Oncogene Proteins c-kit, 2 publications between 2008 and 2018, average publication date August 2013. Receptor, Platelet-Derived Growth Factor beta, 2 publications between 2008 and 2018, average publication date August 2013.

Antibiotics, Antineoplastic
Neutropenia
Doxorubicin
Antineoplastic Agents, Phytogenic
Cyclophosphamide
Lacrimal Duct Obstruction
Paclitaxel
Middle Aged
Fluorouracil
Antineoplastic Combined Chemotherapy Protocols
Neoplasm Metastasis
Breast Neoplasms
Antineoplastic Agents, Hormonal
Taxoids
Receptors, Estrogen
Receptor, ErbB-2
Sirolimus
Proto-Oncogene Proteins c-kit
Receptor, Platelet-Derived Growth Factor beta

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Antibiotics, Antineoplastic	6	1994	2002	December 1997
Neutropenia	9	1984	2023	July 2000
Doxorubicin	30	1984	2015	April 2001
Antineoplastic Agents, Phytogenic	12	1998	2003	June 2001
Cyclophosphamide	21	1984	2012	September 2001
Lacrimal Duct Obstruction	2	2001	2002	September 2001
Paclitaxel	19	1993	2015	October 2002
Middle Aged	77	1984	2019	May 2003
Fluorouracil	20	1995	2012	June 2003
Antineoplastic Combined Chemotherapy Protocols	46	1984	2023	December 2003
Neoplasm Metastasis	21	1993	2019	December 2004
Breast Neoplasms	76	1992	2019	February 2005
Antineoplastic Agents, Hormonal	7	2000	2011	February 2006
Taxoids	14	1998	2013	May 2006
Receptors, Estrogen	12	2000	2012	February 2007
Receptor, ErbB-2	9	2002	2019	June 2009
Sirolimus	4	2011	2015	June 2012
Proto-Oncogene Proteins c-kit	2	2008	2018	August 2013
Receptor, Platelet-Derived Growth Factor beta	2	2008	2018	August 2013

BOOSER's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (344)

Explore

Co-Authors (71)

Explore

Similar People (60)

Explore

Same Department

Explore